- Home
- JGH vs SPOK Comparison
JGH vs SPOK Comparison
Compare JGH & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JGH
- SPOK
- Stock Information
- Founded
- JGH 2014
- SPOK 2004
- Country
- JGH United States
- SPOK United States
- Employees
- JGH N/A
- SPOK N/A
- Industry
- JGH Investment Managers
- SPOK Telecommunications Equipment
- Sector
- JGH Finance
- SPOK Telecommunications
- Exchange
- JGH Nasdaq
- SPOK Nasdaq
- Market Cap
- JGH 285.5M
- SPOK 318.9M
- IPO Year
- JGH N/A
- SPOK 1992
- Fundamental
- Price
- JGH $12.45
- SPOK $16.54
- Analyst Decision
- JGH
- SPOK Hold
- Analyst Count
- JGH 0
- SPOK 1
- Target Price
- JGH N/A
- SPOK $15.00
- AVG Volume (30 Days)
- JGH 73.9K
- SPOK 180.4K
- Earning Date
- JGH 01-01-0001
- SPOK 04-30-2025
- Dividend Yield
- JGH 9.85%
- SPOK 7.54%
- EPS Growth
- JGH N/A
- SPOK N/A
- EPS
- JGH N/A
- SPOK 0.77
- Revenue
- JGH N/A
- SPOK $139,038,000.00
- Revenue This Year
- JGH N/A
- SPOK $2.26
- Revenue Next Year
- JGH N/A
- SPOK $0.14
- P/E Ratio
- JGH N/A
- SPOK $21.51
- Revenue Growth
- JGH N/A
- SPOK N/A
- 52 Week Low
- JGH $10.36
- SPOK $13.55
- 52 Week High
- JGH $12.85
- SPOK $17.96
- Technical
- Relative Strength Index (RSI)
- JGH 54.89
- SPOK 59.93
- Support Level
- JGH $12.35
- SPOK $13.55
- Resistance Level
- JGH $12.47
- SPOK $16.60
- Average True Range (ATR)
- JGH 0.14
- SPOK 0.61
- MACD
- JGH 0.07
- SPOK 0.21
- Stochastic Oscillator
- JGH 85.77
- SPOK 95.22
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.
About SPOK Spok Holdings Inc.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.